Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04646499 · ClinicalTrials.gov registry record · NA

Feasibility of Gamma Transcranial Alternating Current Stimulation to Reduce Beta-amyloid Load and Improve Memory

A NA study of Mild Cognitive Impairment, sponsored by University of California, San Francisco.

Completed
Registry status
NA
Development phase
14
Enrollment target
1
Study location

NCT04646499 is a NA study of Mild Cognitive Impairment that has completed, run by University of California, San Francisco. The registered enrollment target is 14 participants, below the 1,270-participant average among 205 other Mild Cognitive Impairment trials with a reported enrollment target (99% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04646499, a NA study of Mild Cognitive Impairment, has completed, sponsored by University of California, San Francisco.

COMPLETED
Registry status
NA
Development phase
14 participants
Enrollment target
1
Study location

Study Summary

This project assessed the feasibility of transcranial alternating current stimulation in the gamma band to lower beta-amyloid load and improve memory performance.

Conditions Studied

Interventions

  • DEVICE Transcranial alternating current stimulation

Study Locations (1)

California

  • University of California, San Francisco - San Francisco

Trial Details

FieldValue
Enrollment Target 14 participants
Start Date 2021-01-18
Est. Completion 2022-05-31
Phase NA

What the Registry Record Tells You About NCT04646499

The ClinicalTrials.gov registry entry for NCT04646499 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 14 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 1,270-participant average among 205 other Mild Cognitive Impairment trials with a reported enrollment target (99% lower). The listed sponsor is University of California, San Francisco, which has 1,713 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Mild Cognitive Impairment appearing as the primary indexed condition, and to 1 intervention - of which Transcranial alternating current stimulation is the first listed.

NCT04646499 reports 1 study location spanning 1 distinct geographic area - top geographies include California.

Frequently Asked Questions

What is clinical trial NCT04646499 about?

NCT04646499 is a clinical study titled "Feasibility of Gamma Transcranial Alternating Current Stimulation to Reduce Beta-amyloid Load and Improve Memory". This project assessed the feasibility of transcranial alternating current stimulation in the gamma band to lower beta-amyloid load and improve memory performance.

What is the current status of trial NCT04646499?

This trial is currently completed. It is a NA study. The enrollment target is 14 participants. The study started on 2021-01-18. Estimated completion is 2022-05-31.

What conditions does trial NCT04646499 study?

This clinical trial studies the following conditions: Mild Cognitive Impairment.

What interventions are being tested in trial NCT04646499?

The interventions under investigation include: Transcranial alternating current stimulation (DEVICE).

Who is sponsoring clinical trial NCT04646499?

This trial is sponsored by University of California, San Francisco, which has 1,713 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT04646499 being conducted?

This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Mild Cognitive Impairment

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.